Marvin Zelen

Q: What Schools Are Affiliated With Marvin Zelen

Marvin Zelen is affiliated with the following schools: Harvard University, University of Maryland, College Park, University at Buffalo, City College of New York, University of Wisconsin–Madison, American University

Marvin Zelen's AcademicInfluence.com Rankings

Marvin Zelen

Mathematics

#3877

World Rank

#5616

Historical Rank

#1391

USA Rank

Statistics

#194

World Rank

#245

Historical Rank

#82

USA Rank

mathematics Degrees

Download Badge

Mathematics

Why Is Marvin Zelen Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Marvin Zelen was Professor Emeritus of Biostatistics in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health , and Lemuel Shattuck Research Professor of Statistical Science . During the 1980s, Zelen chaired HSPH's Department of Biostatistics. Among colleagues in the field of statistics, he was widely known as a leader who shaped the discipline of biostatistics. He "transformed clinical trial research into a statistically sophisticated branch of medical research."

(See a Problem?)

Marvin Zelen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mathematical Theory of Reliability (1965) (1749)
Effect of screening and adjuvant therapy on mortality from breast cancer (2005) (1380)
Effect of screening and adjuvant therapy on mortality from breast cancer. (2006) (1204)
A new design for randomized clinical trials. (1979) (972)
Rethinking centrality: Methods and examples☆ (1989) (872)
1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings. (1975) (704)
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. (2009) (600)
The randomization and stratification of patients to clinical trials. (1974) (560)
Effect of screening mammography on breast-cancer mortality in Norway. (2010) (529)
Keynote address on biostatistics and data retrieval. (1973) (470)
Play the Winner Rule and the Controlled Clinical Trial (1969) (433)
On the theory of screening for chronic diseases (1969) (405)
Statistical Investigation of the Fatigue Life of Deep-Groove Ball Bearings (1956) (402)
Estimation of exponential survival probabilities with concomitant information. (1965) (367)
The analysis of several 2× 2 contingency tables (1971) (288)
Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. (1989) (257)
An Analysis of Contaminated Well Water and Health Effects in Woburn, Massachusetts (1986) (226)
Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. (1980) (218)
Semi-Markov models for partially censored data (1978) (197)
Statistical theory of reliability (1963) (143)
Screening sensitivity and sojourn time from breast cancer early detection clinical trials: mammograms and physical examinations. (2001) (129)
Randomized consent designs for clinical trials: an update. (1990) (128)
Ethics and statistics in randomized clinical trials. (1991) (126)
Some pitfalls in the evaluation of screening programs. (1969) (117)
ALCOHOL CONSUMPTION AND BREAST CANCER (1983) (116)
Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients. (1997) (102)
Application of Exponential Models to Problems in Cancer Research (1966) (102)
Optimal scheduling of examinations for the early detection of disease (1993) (102)
A randomized trial of adjuvant combination chemotherapy with or without prednisone in premenopausal breast cancer patients with metastases in one to three axillary lymph nodes. (1985) (100)
Normal approximation to the chi-square and non-central F probability functions (1960) (93)
Weak generalized inverses and minimum variance linear unbiased estimation (1964) (89)
Factorial Experiments in Life Testing (1959) (84)
Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer. (1985) (80)
Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors. (1983) (80)
Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group. (1982) (77)
Clinical Trials and Sample Size Considerations: Another Perspective (2000) (75)
Scheduling Periodic Examinations for the Early Detection of Disease: Applications to Breast Cancer (1998) (74)
A semi-markov model for clinical trials (1965) (72)
The Robustness of Life Testing Procedures Derived from the Exponential Distribution (1961) (70)
A stochastic model for predicting the mortality of breast cancer. (2006) (66)
IMMUNOCOMPETENCE, IMMUNODEFICIENCY AND PROGNOSIS IN CANCER * (1976) (65)
Fractional factorial experiment designs for factors at three levels (1961) (65)
Strategy and alternate randomized designs in cancer clinical trials. (1982) (65)
Forward and Backward Recurrence Times and Length Biased Sampling: Age Specific Models (2004) (62)
Are primary cancer prevention trials feasible? (1988) (60)
Studies of leukocyte kinetics by liquid scintillation counting in normal individuals and in patients with chronic myelocytic leukemia. (1966) (59)
A Calculus for Factorial Arrangements (1962) (57)
Case-control studies and Bayesian inference. (1986) (54)
Early detection of disease and scheduling of screening examinations (2004) (53)
Applications of the Calculus of Factorial Arrangements. I. Block and Direct Product Designs (1963) (52)
Parametric estimation procedures for screening programmes: Stable and nonstable disease models for multimodality case finding (1999) (51)
Analysis of multifactor classifications with unequal numbers of observations. (1966) (47)
Alternatives to classic randomized trials. (1981) (42)
Overdiagnosis in early detection programs. (2004) (38)
A hypothesis for the natural time history of breast cancer. (1968) (37)
Therapeutic trials in the management of metastatic brain tumors by different time/dose fraction schemes of radiation therapy. (1977) (36)
The use of prognostic factors in predicting survival for breast cancer patients. (1966) (36)
Multinomial response models (1991) (33)
Modelling the early detection of breast cancer. (2003) (31)
Planning clinical trials to evaluate early detection programmes (1997) (30)
CHEMOTHERAPEUTIC EFFECTS ON MAMMALIAN TUMOR CELLS. I. MODIFICATION OF LEUKEMIA L1210 GROWTH KINETICS AND KARYOTYPE WITH AN ALKYLATING AGENT. (1965) (30)
The Weighted Compounding of Two Independent Significance Tests (1959) (28)
Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution. (2005) (28)
Testing the Independence of Two Diagnostic Tests (2001) (26)
Mortality Modeling of Early Detection Programs (2008) (25)
Testing hypotheses with binary data subject to misclassification errors: Analysis and experimental design (1991) (24)
Modeling the impact of population screening on breast cancer mortality in the United States. (2011) (24)
MULTI-CENTER CLINICAL TRIALS: RANDOMIZATION AND ANCILLARY STATISTICS. (2008) (24)
Bounds on a distribution function that are functions of moments to order four (1954) (24)
Statistical options in clinical trials. (1977) (24)
Return of Leucocytes to the Bone Marrow in Chronic Myelogenous Leukaemia (1965) (23)
Applications of the Calculus for Factorial Arrangements II: Two Way Elimination of Heterogeneity (1964) (22)
Biostatisticians, biostatistical science and the future (2006) (22)
The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update (2018) (21)
Effect of length sampling bias on labeled mitotic index waves. (1971) (21)
Assessment of adjuvant trials in breast cancer. (1986) (18)
Fractional Factoral Experiment Design for Factors at Three Levels. (1960) (18)
SOME FACTORS AFFECTING TUMOR RESPONSE AFTER LASER RADIATION. (1965) (18)
Graphs for Bivariate Normal Probabilities (1960) (17)
Modeling and Optimization in Early Detection Programs with a Single Exam (2002) (17)
Referent sampling, family history and relative risk: the role of length-biased sampling. (2001) (17)
EXPERIMENTAL RESULTS FROM EXPOSURE OF CLOUDMAN S‐91 MELANOMA IN THE CDBA/2F1 HYBRID MOUSE TO NEODYMIUM OR RUBY LASER RADIATION (1965) (17)
Chemotherapeutic effects on mammalian tumor cells. 3. Modification of leukemia L1210 growth kinetics with an antimetabolite. (1966) (16)
THE ANALYSIS OF COVARIANCE FOR INCOMPLETE BLOCK DESIGNS (1957) (16)
Biostatistical science as a discipline: a look into the future. (1983) (15)
Randomised consent trials (1992) (15)
A METHOD FOR PREDICTING MALIGNANT TUMOR DESTRUCTION BY LASER RADIATION. (1965) (15)
Re: Long-term survival and mortality in prostate cancer treated with noncurative intent. (1996) (15)
The Analysis of Incomplete Block Designs (1957) (15)
Risks of cancer and families. (2005) (14)
Intermediate clinical events, surrogate markers and survival (1995) (14)
An investigation of a reported cancer cluster in Randolph, Massachusetts. (1989) (14)
Designing cancer prevention trials: a stochastic model approach. (2000) (14)
Oncolysis with Laser Energy Combined with Chemotherapy (1965) (13)
The Use of Group Divisible Designs for Confounded Asymmetrical Factorial Arrangements (1958) (13)
Models and the early detection of disease: methodological considerations. (2002) (12)
Comparing the Survival of Two Groups with an Intermediate Clinical Event (2001) (11)
The Education of Biometricians (1969) (10)
A STOCHASTIC MODEL FOR THE INTERPRETATION OF CLINICAL TRIALS. (1963) (10)
Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011). (2016) (9)
A Note on Partially Balanced Designs (1954) (9)
Innovations in the design of clinical trials in breast cancer (2005) (9)
Theory and Practice of Clinical Trials (2003) (9)
Early stopping, interim analyses, and monitoring committees: what are the tradeoffs? (1987) (8)
[Linear Estimation of a Regression Relationship from Censored Data Part I: Simple Methods and Their Application]: Discussion No. 1 (1972) (8)
The training of biostatistical scientists (2003) (8)
Preliminary report on the treatment of nonresectable cancer of the lung. (1974) (7)
Planning Clinical Trials (2003) (6)
Quality of institutional participation in multicenter trials. (1982) (6)
Urn Sampling and the Proportional Hazard Model (1998) (6)
The contributions of Jerome Cornfield to the theory of statistics. (1982) (6)
Commentary on “Randomization and Optimal Design” (1983) (5)
Inferring the natural time history of breast cancer: Implications for tumor growth rate and early detection (2005) (5)
Statistical issues in the planning of prevention studies. (1988) (4)
Statistical models for screening: planning public health programs. (2002) (4)
Waiting for a Bus: Does It Explain Age-Dependent Differences in Response to Chemotherapy of Early Breast Cancer? (1978) (4)
Planning of randomized early detection trials (2004) (4)
Strategy and Options in Clinical Trials (1981) (3)
Data analysis methods for inferring the natural history of chronic diseases. (1971) (3)
ANALYSIS FOR SOME PARTIALLY BALANCED INCOMPLETE BLOCK DESIGNS HAVING A MISSING BLOCK (1954) (3)
The reporting of clinical trials: counting is not easy. (1989) (3)
The theory of case-control studies for early detection programs. (2003) (3)
Exact significance tests for contingency tables embedded in a 2ⁿ (1972) (3)
Statistical theory of reliability : proceedings of an advanced seminar conducted by the Mathematics Research Center, United States Army, at the University of Wisconsin, Madison, May 8-10, 1962 (1963) (3)
Experimental design issues for the early detection of disease: novel designs. (2002) (3)
Exact tests for exponential regression (2000) (3)
Panel report. Interdisciplinary group on clinical trials (biostatistics). (1973) (2)
Randomized clinical trials (2010) (2)
Types of Clinical Trials (2003) (2)
Interim Analyses, Multiple Looks at Data, and Early Stopping (2003) (2)
THE ROLE OF CONSTRAINTS IN THE THEORY OF LEAST SQUARES (1962) (2)
Falsification of Data (2003) (2)
Remembrances of Max Halperin. (1990) (2)
The remission and relapse status of acute leukemia as studied by the in vitro uptake of tritiated thymidine by peripheral blood leukocytes. (1968) (1)
Some applications of statistical sampling methods to outgoing letter mail characteristics (1958) (1)
S20 Changing the guidelines for breast cancer screening: modeling mammography benefits and harms (2011) (1)
The participation of community hospitals in cancer clinical trials: results and impact of the Eastern Cooperative Oncology Group Program. (1983) (1)
APPLICATIONS OF THE CALCULUS FOR FACTORIAL ARRANGEMENTS II: UNEQUAL NUMBERS IN THE ANALYSIS OF VARIANCE. (1964) (1)
[Ethics and Statistics in Randomized Clinical Trials]: Comment: The Ethos of Clinical Trials (1991) (1)
THE INTERPRETATION OF CLINICAL TRIALS. (1965) (1)
Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors. (1983) (1)
The Smirnov Two-Sample Statistic D mn (n ≤ m ≤ 20) (1962) (1)
Bibliography of Statistical Literature 1950–1958 (1963) (1)
The Radiation Therapy Oncology Group: a progress report. (1978) (1)
Climate of reason. (1981) (1)
S10 Planning clinical trials to evaluate early detection programs (1996) (1)
Some fractional factorial arrangements for factors at two levels (1954) (1)
INTRODUCTORY LECTURES ON THE STATISTICAL DESIGN OF EXPERIMENTS (1962) (1)
Entrepreneurship, Statistics, and Forming Your Own Company (2004) (0)
Arsenin { Kunugui Theorem and Weak Forms of Borel Bimeasurability (1999) (0)
Setting priorities for cancer control: an approach. (1984) (0)
Alcohol consumption and breast cancer. (1983) (0)
Discussion No. 1 (1972) (0)
Urn sampling, interval censoring and proportional hazard models (2009) (0)
Strategy of Experimentation (2003) (0)
Screening S ensitivity a nd S ojourn T ime F rom B reast Cancer E arly D etection C linical T rials: M ammograms a nd Physical E xaminations (2001) (0)
Chemoprevention Breast Cancer Workshop, November 20, 1987 Panel Discussions (1988) (0)
Reporting of Clinical Trials (2003) (0)
Book Reviews: Sampling Technique (1953) (0)
Role of Compliance (2003) (0)
An introduction to concepts in clinical trials (1992) (0)
Data Collection and Forms Design (2003) (0)
Statistical Assessment of the Life Characteristic: A Bibliographic Guide. (1965) (0)
Authors' Reply (0)
Testing hupotheses with binary data subject to misclassificaton errors: Analysis and experimental design (1992) (0)
Harvard University Department of Biostatistics (2012) (0)
RESPONSE: Re: Risks of Cancer and Families (2006) (0)
COMMENT ON: LONG-TERM SURVIVAL AND MORTALITY IN PROSTATE CANCER TREATED WITH NONCURATIVE INTENT. AUTHORS' REPLY (1996) (0)
Alternatives to classical randomized trials (1985) (0)
Pilot studies and new agent programs of the Eastern Cooperative Oncology Group. (1980) (0)
Handout - IMS and ISI Meetings in Ottawa, 8/27/63. Applications of the Factorial Calculus to General Unequal Numbers Analyses (1963) (0)
regions, multiple decisions and multiple comparisons; Part II comprises normal distribution, exponential distribution, other distributions. Included are seventy assorted tables. There is a. (1963) (0)
Abstract: "Design for Two-way Elimination of Heterogeneity" (1964) (0)
ONE-SIDED VS TWO-SIDED SIGNIFICANCE TESTS. REPLY (1991) (0)
Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer? (1978) (0)
Contributions to Order Statistics (1963) (0)
Sampling Technique . William G. Cochran. New York: Wiley; London: Chapman & Hall, 1953. 330 pp. Illus. $6.50. (1953) (0)
A Guide to Operational Research (1962) (0)
[Biostatistics and Bayes]: Comment (1990) (0)
16. Early Detection of Diseases (2017) (0)

This paper list is powered by the following services:

Other Resources About Marvin Zelen

en.wikipedia.org

What Schools Are Affiliated With Marvin Zelen?

Marvin Zelen is affiliated with the following schools: